BioScrip (NASDAQ:BIOS) was downgraded by stock analysts at Sidoti from a “buy” rating to a “neutral” rating in a report issued on Thursday, TheFlyOnTheWall.com reports. BioScrip Inc (NASDAQ:BIOS) shares after opening at $7.29 on last trade day and at the end of the day closed at $7.28. Company price to sales ratio in past twelve months was calculated as 0.63. BioScrip Inc (NASDAQ:BIOS) showed a positive weekly performance of 1.25%.
Amedisys Inc (NASDAQ:AMED), a home health and hospice company, has reported its financial results for the fourth quarter and year ended December 31, 2013. In a release on March 12, the Company noted Three-Month Periods Ended December 31, 2013 and 2012 – After adding back for the 2013 period, $9.6 million ($5.9 million, net of income tax) or $0.19 per diluted share for certain items and after adding back for the 2012 period $151.0 million ($112.5 million, net of income tax) or $3.71 per diluted share for the goodwill and other intangibles impairment charge. Amedisys Inc (NASDAQ:AMED) shares advanced 2.27% in last trading session and ended the day on $14.41. AMED return on equity ratio is recorded as -44.10% and its return on assets is -26.70%. Amedisys Inc (NASDAQ:AMED) yearly performance is 76787%.
March 12, 14 – Moody’s Investors service, the credit rating wing of Moody’s Corporation (MCO), has recently downgraded the rating outlook on Gentiva Health Services, Inc. (NASDAQ:GTIV) to negative from stable. These ratings include the Corporate Family Rating (CFR) of “B3”, Probability Default Rating (:PDR) of “B3–PD” and speculative grade liquidity rating of “SGL–3” which were also affirmed. Gentiva Health Services, Inc. (NASDAQ:GTIV) shares moved down -0.45% in last trading session and was closed at $8.83, while trading in range of $8.66 – $8.87. Gentiva Health Services, Inc. (NASDAQ:GTIV) year to date (YTD) performance is -28.85%.
Addus Homecare Corporation (NASDAQ:ADUS) weekly performance is -23.58%. On last trading Addus Homecare (NASDAQ:ADUS) was downgraded by Sidoti from a “buy” rating to a “neutral” rating in a research note issued on Tuesday, TheFlyOnTheWall.com reports. They currently have a $30.00 price objective on the stock. Sidoti’s price target points to a potential upside of 7.95% from the company’s current price. day company shares ended up $21.68. Addus Homecare Corporation (NASDAQ:ADUS) distance from 50-day simple moving average (SMA50) is -14.69%. Analysts mean target price for the company is $30.75.